DrugPatentWatch Database Preview
Pertuzumab - Biologic Drug Details
Summary for pertuzumab
| Tradenames: | 1 |
| Patents: | 144 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for pertuzumab |
Pharmacology for pertuzumab
| Mechanism of Action | HER2/Neu/cerbB2 Antagonists |
US Patents for pertuzumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Array BioPharma Inc. (Boulder, CO) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Pharmacyclics LLC (Sunnyvale, CA) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | University of Georgia Research Foundation, Inc. (Athens, GA) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | MEDIMMUNE, LLC (Gaithersburg, MD) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Celcuity LLC (Minneapolis, MN) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | AbbVie Stemcentrx LLC (North Chicago, IL) | ➤ Sign Up | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for pertuzumab
| Country | Document Number | Estimated Expiration |
|---|---|---|
| New Zealand | 553029 | ➤ Sign Up |
| Japan | 6267304 | ➤ Sign Up |
| South Korea | 20180080371 | ➤ Sign Up |
| Japan | 2009527464 | ➤ Sign Up |
| Japan | 6189274 | ➤ Sign Up |
| Jordan | 2660 | ➤ Sign Up |
| South Korea | 101615715 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for pertuzumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2015 | Austria | ➤ Sign Up | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 90004-6 | Sweden | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS, SOLVATES, HYDRATES OR STEREOISOMERS THEREOF; REG. NO/DATE: EU/1/13/850 20130808 |
| 2015 00006 | Denmark | ➤ Sign Up | PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805 |
| 0717 | Netherlands | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN, SOLVATEN, HYDRATEN OF STEREOISOMEREN DAARVAN; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 642 | Luxembourg | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE ET SES SELS, SOLVATES, HYDRATES OU STEREOISOMERES PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT (IMNOVID); FIRST REGISTRATION DATE: 20130805 |
| 0150005 00140 | Estonia | ➤ Sign Up | PRODUCT NAME: POMALIDOMIID;REG NO/DATE: EU/1/13/850 08.08.2013 |
| 2015000013 | Germany | ➤ Sign Up | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE (IMNOVID); REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
